Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Status:
Unknown status
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare induction chemotherapy
(docetaxel+cisplatin+fluorouracil) plus concurrent chemoradiotherapy with concurrent
chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma (NPC), in
order to confirm the value of induction chemotherapy in NPC patients.
Phase:
Phase 3
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Beijing Cancer Hospital Cancer Hospital of Guangxi Medical University Central South University First People's Hospital of Foshan Fudan University Guangzhou Medical University Huazhong University of Science and Technology Jiangsu Cancer Institute & Hospital Jiangxi Provincial Cancer Hospital The Third Affiliated Hospital of Harbin Medical University West China Hospital Zhejiang Cancer Hospital